Companies: 10,795·Total market cap: $144.5T
Intercept Pharmaceuticals, Inc.

Intercept Pharmaceuticals, Inc.

ICPTNASDAQHealthcare
$19.00
+$0.04(+0.21%)
Market Cap$794694000
P/E Ratio
52W High$21.86
52W Low$8.82
Overview

Intercept Pharmaceuticals, Inc. (ICPT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ICPT · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.41icpt eps ttm · icpt earnings per shareEarnings history
PE Ratio (TTM)icpt pe ratio ttm · icpt price to earningsPE Ratio deep dive
Revenue (TTM)$317.7Micpt revenue ttm · icpt annual revenueFull revenue history
Dividend YieldNo Dividenddoes icpt pay dividends · icpt dividend yieldDividend history
Shares Outstanding33.8Micpt shares outstanding · icpt floatShares outstanding history
Next EarningsTBAicpt earnings date · icpt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2022Revenue$285.7M▼ 21.39% YoY
202020212022
intercept pharmaceuticals, inc. revenue · icpt revenue 2022
FY 2022Net Income$115.2M▲ +179.42% YoY
202020212022
intercept pharmaceuticals, inc. net income · icpt profit 2022
FY 2022EPS$3.41▲ +174.95% YoY
202020212022
icpt eps · intercept pharmaceuticals, inc. earnings per share 2022
TTM:Revenue: $317.7MNet Income: -$58.6MEPS: $-1.41View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold40 analystsis icpt a buy · icpt analyst rating
Strong Buy
0
Buy
16
Hold
19
Sell
5
Strong Sell
0
12-Month Price Target
$10.00Low
$19.00Current
$22.11Avg Target16.37% upside
$44.00High
icpt price target · icpt 12 month forecast

Total: 40 · Buy rate: 40.0%

The ICPT analyst consensus is Hold, based on ratings from 40 Wall Street analysts over the past 3 months. The average 12-month price target is $22.11, representing +16.37% upside from the current price of $19.00.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.21%
3M+72.81%
YTD+51.64%
1Y+35.81%
5Y-82.21%

About Intercept Pharmaceuticals, Inc.

CEOJerome B. Durso
IPO DateOct 11, 2012
Employees341
CountryUS

Intercept Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the advancement and market launch of therapies designed to treat progressive, non-viral liver conditions. Its operational re…

what is intercept pharmaceuticals, inc. · icpt stock overview · intercept pharmaceuticals, inc. company profile · who is intercept pharmaceuticals, inc. ceo · icpt NASDAQ · intercept pharmaceuticals, inc. headquarters · intercept pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Intercept Pharmaceuticals, Inc. (ICPT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 11, 2012. As of the latest trading session, ICPT stock price is $19.00, with a market capitalization of $794.7M. The stock has returned +35.81% over the past 12 months and +51.64% year-to-date.

According to 40 Wall Street analysts, the consensus rating for Intercept Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $22.11. In fiscal year 2022, Intercept Pharmaceuticals, Inc. reported revenue of $285.7M and net income of $115.2M. For detailed data — including Intercept Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Intercept Pharmaceuticals, Inc. (ICPT) stock price is $19.00. The stock is traded on NASDAQ under the ticker symbol ICPT. The 52-week range is $8.82 – $21.86.

ICPT stock priceICPT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice